• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. TUFTEX OVER-THE-WIRE EMBOLECTOMY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. TUFTEX OVER-THE-WIRE EMBOLECTOMY CATHETER Back to Search Results
Catalog Number 1651-38
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/17/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during a thrombectomy procedure, the balloon ruptured.A replacement device was used, and the procedure was successfully completed.The device was discarded and will not be returned.No patient injury was reported.
 
Additional Manufacturer Narrative
The device was discarded and not available for investigation.Therefore, we could not conclusively determine the root cause of the reported incident.It is possible that procedural factors/anatomical features such as calcification, or plaque caused/contributed to the reported issue.The ifu provides the following warning related to the complications possible when using these devices: in common with other catheterization procedures, complications may occur.These may include intimal disruption, vessel wall perforation, balloon rupture with fragmentation, tip separation, local or systemic infection, arterial thrombosis, local hematomas, air embolus, rupture of aneurysm, arterial spasm, distal embolus of blood clots or arteriosclerotic plaque, arterial dissection, and hemorrhage.Exercise caution when encountering extremely diseased vessels.Arterial rupture or balloon failure due to sharp calcified plaque may occur.Excessive handling during insertion, or plaques and other deposits within the vessel may damage the balloon and can increase the possibility of balloon rupture.The possibility of balloon rupture must be taken into account when considering the risks involved in the catheterization procedure.Due to the increased rate of occurrence of this issue, capa 2024-007 was previously implemented to document further investigation of this failure.The production and traceability record for the device was reviewed; no issues were found during manufacturing or packaging that would cause or contribute to the reported event.All quality control tests were completed successfully and met specification.We have not received any other complaints of a similar nature for devices from this lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TUFTEX OVER-THE-WIRE EMBOLECTOMY CATHETER
Common Device Name
EMBOLECTOMY CATHETER
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer Contact
peter song
63 second ave
burlington, MA 01803
9784251683
MDR Report Key23817695
Report Number1220948-2025-00217
Device Sequence Number15969253
Product Code DXE
UDI-Device Identifier00840663100668
UDI-Public(01)00840663100668(11)250123(17)301228(10)OTW00004981(91)1651-38
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K022145
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Distributor
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 12/16/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number1651-38
Device Lot NumberOTW00004981
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/17/2025
Initial Report FDA Received Date12/16/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/23/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-